← Journal of Immunotherapy and Precision Oncology
Papers in Journal of Immunotherapy and Precision Oncology
Page 3 · newest first
- A Wolf in Sheep's Clothing: Systemic Immune Activation Post ImmunotherapyJournal of Immunotherapy and Precision Oncology · 2021
- Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?Journal of Immunotherapy and Precision Oncology · 2021
- Rare Blood Cancers in 2021: Importance of Continued Exchange of IdeasJournal of Immunotherapy and Precision Oncology · 2021
- Inflammation in Myeloid Malignancies: From Bench to BedsideJournal of Immunotherapy and Precision Oncology · 2021
- Novel Therapies in Myeloproliferative Neoplasms: Beyond JAK Inhibitor MonotherapyJournal of Immunotherapy and Precision Oncology · 2021
- Synchronized Tissue Acquisition Techniques for Novel Biomarker Discovery: Are You Ready to Waltz?Journal of Immunotherapy and Precision Oncology · 2021
- JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with MyelofibrosisJournal of Immunotherapy and Precision Oncology · 2021
- Chronic Myelomonocytic Leukemia: Hematopathology PerspectiveJournal of Immunotherapy and Precision Oncology · 2021
- Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint InhibitorsJournal of Immunotherapy and Precision Oncology · 2021
- Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) InhibitorsJournal of Immunotherapy and Precision Oncology · 2021
- Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensJournal of Immunotherapy and Precision Oncology · 2021
- First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced PneumonitisJournal of Immunotherapy and Precision Oncology · 2021
- Targeted Cancer Therapy and Its Ophthalmic Side Effects: A ReviewJournal of Immunotherapy and Precision Oncology · 2021
- Real-World Data on Liquid Biopsy Use in Non-Small Cell Lung Cancer in the Community SettingJournal of Immunotherapy and Precision Oncology · 2021
- Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?Journal of Immunotherapy and Precision Oncology · 2021
- Comprehensive Genomic Profiling-Guided Niraparib Treatment of Triple-Negative Breast Cancer in a Patient With Extensive Brain Metastasis: Case Report and Literature ReviewJournal of Immunotherapy and Precision Oncology · 2021
- Wilms' Tumor 1 (WT1): The Vaccine for CancerJournal of Immunotherapy and Precision Oncology · 2020
- The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in GliomasJournal of Immunotherapy and Precision Oncology · 2020
- Case Report: Metastatic Dedifferentiated Liposarcoma Presenting as Hypereosinophilia in an AdolescentJournal of Immunotherapy and Precision Oncology · 2020
- Role of Infliximab in Immune Checkpoint Inhibitor-Induced PneumonitisJournal of Immunotherapy and Precision Oncology · 2020
- Cancer Epigenomics and Beyond: Advancing the Precision Oncology ParadigmJournal of Immunotherapy and Precision Oncology · 2020
- Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving ImmunotherapyJournal of Immunotherapy and Precision Oncology · 2020
- The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical CancerJournal of Immunotherapy and Precision Oncology · 2020
- Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated ArrhythmiasJournal of Immunotherapy and Precision Oncology · 2020
- Case Report: Sustained Complete Response to PI3K Inhibition in a Patient with Metastatic Breast Cancer Harboring PIK3CA , NF1 , and CDH1 MutationsJournal of Immunotherapy and Precision Oncology · 2020
- Repurposing Interleukin-6 Inhibitors to Combat COVID-19Journal of Immunotherapy and Precision Oncology · 2020
- When Molecular-Targeted Agents Meet Immunotherapy: The Opportunities for Soft Tissue SarcomaJournal of Immunotherapy and Precision Oncology · 2020
- Clinicopathologic Features and Whole Genome Sequencing of a Primary Osteosarcoma of the UterusJournal of Immunotherapy and Precision Oncology · 2020
- Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor CancersJournal of Immunotherapy and Precision Oncology · 2020
- Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging ParadigmsJournal of Immunotherapy and Precision Oncology · 2020
- Pneumocystis Infection in Two Patients Treated with Both Immune Checkpoint Inhibitor and CorticoidsJournal of Immunotherapy and Precision Oncology · 2020
- Review of Immunogenomics and the Role of Tumor Mutational Burden as a Biomarker for Immunotherapy ResponseJournal of Immunotherapy and Precision Oncology · 2019
- Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire SequencingJournal of Immunotherapy and Precision Oncology · 2019
- Review: The Impact of HIV Infection on Cancer Treatment with ImmunotherapyJournal of Immunotherapy and Precision Oncology · 2019
- Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting SystemJournal of Immunotherapy and Precision Oncology · 2019
- Immunotherapy Use in Patients with HIV and Non-Small-Cell Lung Cancer: Current DataJournal of Immunotherapy and Precision Oncology · 2019
- Kaposi's Sarcoma in the ImmunosuppressedJournal of Immunotherapy and Precision Oncology · 2019
- Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature ReviewJournal of Immunotherapy and Precision Oncology · 2019
- Tackling Immunotherapy Resistance: Developing Rational Combinations of Immunotherapy and Targeted DrugsJournal of Immunotherapy and Precision Oncology · 2019
- Extracellular Signal-Regulated Kinase (ERK) Inhibitors in Oncology Clinical TrialsJournal of Immunotherapy and Precision Oncology · 2019
- Toxic Epidermal Necrolysis During Cotherapy with Ipilimumab and NivolumabJournal of Immunotherapy and Precision Oncology · 2018
- Pyoderma Gangrenosum Following Initiation of Immune Checkpoint Inhibitor TherapyJournal of Immunotherapy and Precision Oncology · 2018
- Personalized Cancer Immunotherapy: Today’s Challenge and Tomorrow’s PromiseJournal of Immunotherapy and Precision Oncology · 2018
- Pneumonitis After Precision Oncology Therapies: A Concise ReviewJournal of Immunotherapy and Precision Oncology · 2018
- Understanding the Toxicity of Cancer Immunotherapies: Use of Patient-Reported OutcomesJournal of Immunotherapy and Precision Oncology · 2018
- Bronchiolitis Obliterans after Combination Immunotherapy with Pembrolizumab and IpilimumabJournal of Immunotherapy and Precision Oncology · 2018
- The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ OutcomesJournal of Immunotherapy and Precision Oncology · 2018